Login
Register
Reset Password
Publish & Distribute
Publishing Solutions
Distribution Solutions
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Blog
Contact
Search
EUR
USD
GBP
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Radiology and Oncology
Volume 50 (2016): Issue 4 (December 2016)
Open Access
Virtual modelling of novel applicator prototypes for cervical cancer brachytherapy
Primoz Petric
Primoz Petric
,
Robert Hudej
Robert Hudej
,
Noora Al-Hammadi
Noora Al-Hammadi
and
Barbara Segedin
Barbara Segedin
| Nov 09, 2016
Radiology and Oncology
Volume 50 (2016): Issue 4 (December 2016)
About this article
Previous Article
Next Article
Abstract
Article
Figures & Tables
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Article Category:
Research Article
Published Online:
Nov 09, 2016
Page range:
433 - 441
Received:
Jul 01, 2016
Accepted:
Aug 29, 2016
DOI:
https://doi.org/10.1515/raon-2016-0048
© 2016 Radiol Oncol
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Principles of Target-volume Density Map (TDM) generation and postprocessing on an example of 6 cervical cancer cases. (A) Contours of high risk clinical target volumes (CTVHR – thin white lines) are shown on mid-coronal T2 weighted MRI with the applicator in place. Source channels are depicted as thick white lines. (B) CAT 2 generates the TDM by rigid co-registration of individual CTVHRs on a reference applicator. TDM voxels are assigned target density values, corresponding to the number of encompassing CTVHRs. These values are transformed to grey levels. (C) Resulting TDM DICOM image is exported to treatment planning system where isodensity contours (IDC) are auto-segmented (white dotted lines).
Schematic representation of applicator modelling based on our theoretical example of Target-volume Density Map (TDM). Above: Three virtual applicators are reconstructed on the TDM. Dose distribution is optimized based on a set of specific planning aims for the isodensity contours (IDC) and for residual volumes at risk (RVR). The optimized prescription isodoses for individual applicators are shown as thick dotted lines. (A) Standard intracavitary applicator: limited possibility for optimization. The planning aim is achieved for ≈70% IDC. (B) Combined intracavitary and interstitial applicator with parallel parametrial needles (Vienna-type): planning aim is achieved for ≈95% IDC. (C) Combined intracavitary and interstitial applicator with parallel and oblique parametrial needles: planning aim as achieved for ≈100 % IDC. (D) Characteristic curves for the IDC of the three applicator types. RVR curves are not shown. Shaded areas under characteristic curves represents IDC ranges in which certain applicator is able to achieve the planning aim. Arbitrary planning aim and applicator thresholds are marked by dotted lines.